FDA Approves Novartis' Hypertension Drug Tekturna
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on March 8, 2007

"Renin angiotensin system activity contributes to many of the complications associated with high blood pressure," said Marc A. Pfeffer, MD, PhD, Professor of Medicine at the Harvard Medical School and cardiologist at Brigham & Women's Hospital. "By inhibiting this important system at its origin, renin production, a direct renin inhibitor such as Tekturna offers an exciting novel therapeutic option for treating hypertension."
The drug has been approved as monotherapy, as well as in combination with other medications to control blood blood pressure. It is expected to be available in the pharmacies
within the month.For more info, see Novartis press release or the financial report from CNN Money.
Permalink: FDA Approves Novartis' Hypertension Drug Tekturna
Tags:
hypertension
Tekturna
blood+pressure
cardiovascular+disease
heart+health
health
biotech
hypertension
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/57100

Mr Wong
